These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 24770573)
1. Cognitive functioning and insight in schizophrenia and in schizoaffective disorder. Birindelli N; Montemagni C; Crivelli B; Bava I; Mancini I; Rocca P Riv Psichiatr; 2014; 49(2):77-83. PubMed ID: 24770573 [TBL] [Abstract][Full Text] [Related]
2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)]. Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451 [TBL] [Abstract][Full Text] [Related]
3. [Competitive employment in schizophrenia: clinical and neuropsychological correlates and quality of life]. Birindelli N; Castagna F; Giugiario M; Graffino M; Mingrone C; Sandei L; Rocca P Riv Psichiatr; 2012; 47(2):89-95. PubMed ID: 22622245 [TBL] [Abstract][Full Text] [Related]
4. [Relationship between insight and self-reported quality of life among shizophrenic patients]. Aghababian V; Auquier P; Baumstarck-Barrau K; Lançon C Encephale; 2011 Jun; 37(3):162-71. PubMed ID: 21703431 [TBL] [Abstract][Full Text] [Related]
5. Premorbid adjustment in schizophrenia and schizoaffective disorder. Saracco-Alvarez R; Rodríguez-Verdugo S; García-Anaya M; Fresán A Psychiatry Res; 2009 Feb; 165(3):234-40. PubMed ID: 19162333 [TBL] [Abstract][Full Text] [Related]
6. Cognitive function in schizoaffective disorder and clinical subtypes of schizophrenia. Goldstein G; Shemansky WJ; Allen DN Arch Clin Neuropsychol; 2005 Mar; 20(2):153-9. PubMed ID: 15708725 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of depression and its relationship with other clinical characteristics in a sample of patients with stable schizophrenia. Majadas S; Olivares J; Galan J; Diez T Compr Psychiatry; 2012 Feb; 53(2):145-51. PubMed ID: 21621754 [TBL] [Abstract][Full Text] [Related]
8. The impact of insight on functioning in patients with schizophrenia or schizoaffective disorder receiving risperidone long-acting injectable. Gharabawi G; Bossie C; Turkoz I; Kujawa M; Mahmoud R; Simpson G J Nerv Ment Dis; 2007 Dec; 195(12):976-82. PubMed ID: 18091190 [TBL] [Abstract][Full Text] [Related]
9. Relationships of age at onset with clinical features and cognitive functions in a sample of schizophrenia patients. Bellino S; Rocca P; Patria L; Marchiaro L; Rasetti R; Di Lorenzo R; Paradiso E; Bogetto F J Clin Psychiatry; 2004 Jul; 65(7):908-14. PubMed ID: 15291678 [TBL] [Abstract][Full Text] [Related]
10. Determinants of work outcome in schizophrenia and schizoaffective disorder: role of cognitive function. Kaneda Y; Jayathilak K; Meltzer HY Psychiatry Res; 2009 Sep; 169(2):178-9. PubMed ID: 19646764 [TBL] [Abstract][Full Text] [Related]
11. Determinants of work outcome in neuroleptic-resistant schizophrenia and schizoaffective disorder: cognitive impairment and clozapine treatment. Kaneda Y; Jayathilak K; Meltzer H Psychiatry Res; 2010 Jun; 178(1):57-62. PubMed ID: 20452677 [TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of schizoaffective disorder. Are there any differences with respect to schizophrenia? Pinna F; Sanna L; Perra V; Pisu Randaccio R; Diana E; Carpiniello B; Riv Psichiatr; 2014; 49(1):41-9. PubMed ID: 24572583 [TBL] [Abstract][Full Text] [Related]
13. Exploring the borders of the schizoaffective spectrum: a categorical and dimensional approach. Peralta V; Cuesta MJ J Affect Disord; 2008 May; 108(1-2):71-86. PubMed ID: 18029027 [TBL] [Abstract][Full Text] [Related]
14. Insight and neuropsychological function in patients with schizophrenia and bipolar disorder with psychotic features. Arduini L; Kalyvoka A; Stratta P; Rinaldi O; Daneluzzo E; Rossi A Can J Psychiatry; 2003 Jun; 48(5):338-41. PubMed ID: 12866340 [TBL] [Abstract][Full Text] [Related]
15. Cross-sectional similarities and differences between schizophrenia, schizoaffective disorder and mania or mixed mania with mood-incongruent psychotic features. Pini S; de Queiroz V; Dell'Osso L; Abelli M; Mastrocinque C; Saettoni M; Catena M; Cassano GB Eur Psychiatry; 2004 Feb; 19(1):8-14. PubMed ID: 14969775 [TBL] [Abstract][Full Text] [Related]
16. Two-year follow-up of cognitive functions in schizophrenia spectrum disorders of adolescent patients treated with electroconvulsive therapy. de la Serna E; Flamarique I; Castro-Fornieles J; Pons A; Puig O; Andrés-Perpiña S; Lázaro L; Garrido JM; Bernardo M; Baeza I J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):611-9. PubMed ID: 22136098 [TBL] [Abstract][Full Text] [Related]
17. Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia. Kim SW; Shin IS; Kim JM; Lee SH; Lee YH; Yang SJ; Yoon JS Hum Psychopharmacol; 2009 Oct; 24(7):565-73. PubMed ID: 19790174 [TBL] [Abstract][Full Text] [Related]
18. The influence of sex on cognitive insight and neurocognitive functioning in schizophrenia. Kao YC; Liu YP; Lien YJ; Lin SJ; Lu CW; Wang TS; Loh CH Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():193-200. PubMed ID: 23419242 [TBL] [Abstract][Full Text] [Related]
19. Schizoaffective disorder: a form of schizophrenia or affective disorder? Evans JD; Heaton RK; Paulsen JS; McAdams LA; Heaton SC; Jeste DV J Clin Psychiatry; 1999 Dec; 60(12):874-82. PubMed ID: 10665641 [TBL] [Abstract][Full Text] [Related]
20. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders]. Liraud F; Verdoux H Encephale; 2002; 28(2):160-8. PubMed ID: 11972143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]